Philip Morris: Smoke-Free Future or Continued Cigarette Profits?

Philip Morris International (PMI) is undertaking a significant transformation, attempting to reposition itself around smoke-free alternatives while still managing the financial realities of its global cigarette business. The roughly $280 billion company, synonymous with the Marlboro brand, aims to derive more than two-thirds of its net revenue from smoke-free products by 2030. This transition presents a delicate balancing act: building new growth areas while sustaining the revenue base that funds the shift.

Seth Kaufman, PMI’s U.S. Chief commercial officer, characterizes the strategy as a convergence of business objectives and public health goals. The core idea, he explains, is to capture the existing adult nicotine consumer base and guide them toward less harmful alternatives to cigarettes. Kaufman highlights the scale of the opportunity, noting that there are approximately 45 million legal-age nicotine users in the U.S., with over 30 million still consuming nicotine in its most harmful form. Successfully transitioning these users, the company argues, allows for growth while simultaneously contributing to harm reduction.

This narrative forms the cornerstone of PMI’s public image, but it also reveals underlying tensions. While PMI actively markets itself as a smoke-free company in the U.S., focusing on alternatives, combustible products remain a substantial revenue source internationally. The company defends this approach by asserting that revenue from traditional cigarettes supports investment and expansion in smoke-free platforms – a position viewed by some as a legitimate pathway to transition, and by others as a means of continuing to profit from cigarettes in certain markets while cultivating an image as a health-conscious innovator elsewhere.

The success of this strategy hinges on the consumer approach driving PMI’s U.S. Business. Kaufman’s background offers insight into this approach. Having previously worked in industries reliant on repeat consumption – soda, coffee, and wine – he emphasizes the importance of building brands that integrate into daily life and foster emotional connections. This experience shapes his current strategic thinking.

“It always, always, always has to start with the consumer,” Kaufman stresses, prioritizing curiosity, empathy, and identifying unmet needs. This framework mirrors classic consumer packaged goods principles applied to a heavily regulated and scrutinized industry. The focus is on understanding and responding to consumer behavior, rather than dictating it.

PMI maintains that its growth strategy is centered on conversion, not expansion, emphasizing a commitment to existing adult nicotine users and explicitly stating it does not aim to create new ones. Kaufman frames growth as inherent to the mission: “Growth is actually inherent in the mission, because there is an audience there that we can talk to, and we can help them make better choices.” However, this conversion-driven growth model has inherent limitations. As the pool of potential switchers diminishes, pressure to maintain returns could potentially clash with the company’s public health messaging.

Cultural factors have also presented unexpected challenges. Nicotine pouches, particularly Zyn, have become increasingly associated with high-stress work environments, especially in the finance and tech sectors, where they are often discussed as productivity enhancers. Kaufman avoids framing the products in terms of performance benefits, instead emphasizing rituals, and occasions. This linguistic approach aims to maintain credibility with public health authorities and mitigate potential regulatory risks by focusing on harm reduction rather than cognitive enhancement.

Kaufman attributes Zyn’s cultural surge to consumer-driven trends, distancing the company from the viral online culture surrounding the product. “I’m always surprised by consumer behavior,” he says, “If I wasn’t surprised by consumer behavior, it would tell me I’m not curious enough, because it’s changing so quickly.” He also points to underserved demographics, such as female smokers, as potential growth areas, indicating plans to tailor flavor profiles and messaging to appeal to this segment.

Internally, PMI’s product development is guided by consumer feedback, focusing on refining the portfolio to address gaps in flavor variety, nicotine strengths, and packaging formats designed for different occasions. “We’re really, really early in understanding what those unmet needs are,” Kaufman explains, highlighting a strategy of continuous adjustment to better align offerings with actual consumer behavior.

As of the end of 2025, smoke-free products already account for 42% of PMI’s net revenue across 106 markets. However, inherent contradictions remain. The company’s smoke-free narrative is supported by revenue from combustible products in other markets. Conversion-driven growth, while promising, ultimately faces a natural ceiling. And the consumer playbook, built on cultivating habits, is now being applied to a future centered on harm reduction.

The key challenge for PMI will be demonstrating that the economics, cultural positioning, and public health narrative remain aligned as the company progresses further into its transformation. According to recent data, smoke-free revenue now accounts for 41.5% of total net sales, totaling approximately $17 billion, and driving operating margins above 40%, with adjusted EPS growth accelerating. The company’s ambition is to have smoke-free products generate over two-thirds of global revenue by 2030.